TScan Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TCRX and other ETFs, options, and stocks.

About TCRX

TScan Therapeutics, Inc. discovers and develops transformative T cell therapies (TCR-T) to treat liquid cancers, solid tumors and other serious diseases. Its platform identifies previously uncharacterized, clinically-derived shared T cell antigens and all off-target TCR interactions, to enable the development of efficacious TCR-Ts. 

CEO
David P. Southwell
CEODavid P. Southwell
Employees
105
Employees105
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2018
Founded2018
Employees
105
Employees105

TCRX Key Statistics

Market cap
42.76M
Market cap42.76M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
31.06K
Average volume31.06K
High today
$2.33
High today$2.33
Low today
$2.11
Low today$2.11
Open price
$2.12
Open price$2.12
Volume
32.88K
Volume32.88K
52 Week high
$7.05
52 Week high$7.05
52 Week low
$1.60
52 Week low$1.60

TCRX Earnings

-$7.69
-$5.00
-$2.31
$0.38
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 8, Pre-Market
ActualExpected Mar 8, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.